BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA (HGG): ANALYSIS OF MONOTHERAPY VERSUS COMBINATION WITH CHEMOTHERAPY FROM A CANADIAN RETROSPECTIVE CHART REVIEW

被引：0
|
作者：
Kavan, Petr [1 ]
Sahebjam, Solmaz [2 ]
Garoufalis, Evgenia [3 ]
Guiot, Marie-Christine [4 ]
Muanza, Thierry
Del Maestro, Rolando [5 ]
Petrecca, Kevin [5 ]
Sharma, Rajesh [3 ]
机构：
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Montreal Neurol Hosp, Inst Neuropathol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG) TREATED WITH BEVACIZUMAB
    Ye, L.
    Hasani, A.
    Nowak, A.
    King, A.
    Long, A.
    Trevenen, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 72 - 72
  • [2] RETROSPECTIVE STUDY OF DASATINIB IN RECURRENT HIGH-GRADE GLIOMA (HGG) PATIENTS WHO FAILED BEVACIZUMAB
    Lu-Emerson, Christine
    Norden, Andrew D.
    Drappatz, Jan
    Quant, Eudocia C.
    Ciampa, Abigail S.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2010, 12 : 38 - 38
  • [3] Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study
    Yin, Jun
    Yin, Wenya
    Zheng, Linlin
    Li, Yimin
    Luo, Cheng
    Zhang, Shuo
    Duan, Lei
    Zhou, Hang
    Cheng, Kai
    Lang, Jinyi
    Xu, Ke
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [4] Retrospective study of dasatinib in recurrent high-grade glioma (HGG) patients who failed bevacizumab.
    Lu-Emerson, C.
    Norden, A. D.
    Drappatz, J.
    Quant, E. C.
    Ciampa, A. S.
    Doherty, L. M.
    LaFrankie, D. C.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Valproic acid and chemotherapy in pediatric high-grade glioma: Retrospective chart review
    Masoudi, Amirhadi
    Ater, Joann L.
    Gopalakrishnan, Vidya
    Amini, Elham
    Nagel, Margaret E.
    Elopre, Marily S.
    Wolff, Johannes
    NEURO-ONCOLOGY, 2007, 9 (04) : 537 - 537
  • [6] Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
    Kulinich, Daniel P.
    Sheppard, John P.
    Nguyen, Thien
    Kondajji, Aditya M.
    Unterberger, Ansley
    Duong, Courtney
    Enomoto, Adam
    Patel, Kunal
    Yang, Isaac
    ACTA NEUROCHIRURGICA, 2021, 163 (07) : 1921 - 1934
  • [7] Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
    Daniel P. Kulinich
    John P. Sheppard
    Thien Nguyen
    Aditya M. Kondajji
    Ansley Unterberger
    Courtney Duong
    Adam Enomoto
    Kunal Patel
    Isaac Yang
    Acta Neurochirurgica, 2021, 163 : 1921 - 1934
  • [8] RADIOSURGERY VERSUS COMBINATION RADIOSURGERY-BEVACIZUMAB FOR THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMA: A SYSTEMATIC REVIEW
    Kulinich, Daniel
    Sheppard, John
    Nguyen, Thien
    Kondajji, Aditya
    Unterberger, Ansley
    Enomoto, Adam
    Patel, Kunal
    Gopen, Quinton
    Yang, Isaac
    NEURO-ONCOLOGY, 2020, 22 : 188 - 188
  • [9] Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study
    Fat, Mary Jane Lim
    Maurice, Catherine
    Maganti, Manjula
    Mason, Warren P.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (01) : 56 - 61
  • [10] A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).
    Drappatz, J.
    Raizer, J. J.
    Schiff, D.
    Chi, A. S.
    Batchelor, T.
    Snodgrass, S. M.
    Quant, E. C.
    Norden, A. D.
    Beroukhim, R.
    Grimm, S. A.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Gerard, M.
    Hammond, S.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345